Open AccessComplex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy
Author(s) -
Jennifer A. White,
Francesco R. Simonetti,
Subul Beg,
Natalie F McMyn,
Weiwei Dai,
Niklas Bachmann,
Jun Lai,
William C Ford,
Christina Bunch,
Joyce Jones,
Ruy M. Ribeiro,
Alan S. Perelson,
Janet D. Siliciano,
Robert F. Siliciano
Publication year - 2022
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2120326119
Subject(s) - population , virology , virus , biology , antiretroviral therapy , viral replication , human immunodeficiency virus (hiv) , genome , viral load , genetics , gene , medicine , environmental health
Significance In persons living with HIV-1 who start antiretroviral therapy, virus in the blood decreases rapidly to below the detection limit. The decrease occurs in two phases: a rapid initial decrease in the first weeks, followed by a second, slower phase occurring over the next few months. These decay processes are important because infected cells that remain may become part of the stable latent reservoir that prevents cure. The decay in virus levels in blood presumably reflects the loss of infected cells, but the relationship between the decay of free virus and of infected cells has been unclear. Here, we have analyzed this question using an assay that distinguishes between cells with intact and defective forms of the viral genome.